Medication overuse headache: an overview of clinical aspects, mechanisms, and treatments

References

• Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neuro. 2012;19:703–711.
   Google Scholar
• Bendtsen L, Munksgaard S, Tassorelli C, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34:426–433.
   PubMed Web of Science ®Google Scholar
• Global, regional, and national incidence, prevalence, and years lived with disability for. 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602.
   PubMed Web of Science ®Google Scholar
• Linde M, Stovner LJ, Zwart JA, et al. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011;31:585–596.
   PubMed Web of Science ®Google Scholar
• Westergaard ML, Glümer C, Hansen EH, et al. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014;155:2005–2013.
   PubMed Web of Science ®Google Scholar
• Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012;25:290–295.
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.
   Web of Science ®Google Scholar
• Bigal ME, Lipton RB. When migraine progresses: transformed or chronic migraine. Expert Rev Neurother. 2006;6:297–306.
   PubMedGoogle Scholar
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12:455–464.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Chong CD. Medication overuse headache: pathophysiological insights from structural and functional brain MRI research. Headache. 2017;57:1173–1178.
   PubMed Web of Science ®Google Scholar
• Bahra A, Walsh M, Menon S, et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003;43:179–190.
   PubMed Web of Science ®Google Scholar
• Viana M, De Icco R, Allena M, et al. Clinical subtypes of medication overuse headache – findings from a large cohort. Headache. 2019;59:1481–1491.
   PubMed Web of Science ®Google Scholar
• Jay GW, Barkin RL. Primary headache disorders- part 2: tension-type headache and medication overuse headache. Dis Mon. 2017;63:342–367.
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694–1698.
   PubMed Web of Science ®Google Scholar
• Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002;59:1011–1014.
   PubMed Web of Science ®Google Scholar
• Carlsen LN, Munksgaard SB, Jensen RH, et al. Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia. 2018;38:225–236.
   PubMed Web of Science ®Google Scholar
• Grazzi L, Sansone E, Raggi A, et al. Mindfullness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: an effectiveness trial with a one-year follow-up. J Headache Pain. 2017;18:15–37.
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Tepper SJ, Jevoux C, et al. Medication-overuse headache: protocols and outcomes in 149 consecutive patients in a tertiary Brazilian headache center. Headache. 2017;57:87–96.
   PubMed Web of Science ®Google Scholar
• Nielsen M, Carlsen LN, Munksgaard SB, et al. Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trial. Cephalalgia. 2019;39:863–872.
   PubMed Web of Science ®Google Scholar
• Saper JR, Da Silva AN. Medication overuse headache: history, features, prevention and management strategies. CNS Drugs. 2013;27:867–877.
   PubMed Web of Science ®Google Scholar
• Chiang CC, Schwedt TJ, Wang SJ, et al. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016;36:371–386.
   PubMed Web of Science ®Google Scholar
• Dodick DW, Silberstein SD. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia. 2008;28:1207–1217.
   PubMed Web of Science ®Google Scholar
• Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study. Cephalalgia. 2014;34:645–655.
   PubMed Web of Science ®Google Scholar
• Dinner HC. Detoxification for medications overuse headache is not necessary. Cephalalgia. 2002;32:423–427.
   Google Scholar
• Krymchantowski AV, Moreira PF. Clinical presentation of transformed migraine: possible differences among male and female patients. Cephalalgia. 2001;21:558–566.
   PubMed Web of Science ®Google Scholar
• Mathew NT. Chronic daily headache: clinical features and natural history. In: Nappi G, editor. Headache and depression: serotonin pathways as a common clue. New York: Raven Press; 1991. p. 42–51.
   Google Scholar
• Saper JR. Daily chronic headache. Neurol Clin. 1990;8:891–901.
   PubMed Web of Science ®Google Scholar
• Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache. 1992;32:325–329.
   PubMed Web of Science ®Google Scholar
• Spierings EL, Schroevers M, Honkoop PC, et al. Presentation of chronic daily headache: a clinical study. Headache. 1998;38:191–196.
   PubMed Web of Science ®Google Scholar
• Da Silva AN, Lake AE. Clinical aspects of medication overuse headaches. Headache. 2014;54:211–217.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008;48:1157–1168.
   PubMed Web of Science ®Google Scholar
• Kluonaitis K, Petrauskiene E, Ryliskiene K. Clinical characteristics and overuse patterns of medication overuse headache: retrospcetive case-series study. Clin Neurol Neurosurg. 2017;163:124–127.
   PubMed Web of Science ®Google Scholar
• De Felice M, Ossipov MH, Porreca F. Update on medication-overuse headache. Curr Pain Headache Rep. 2011;15:79–83.
   PubMed Web of Science ®Google Scholar
• Headache classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
   PubMed Web of Science ®Google Scholar
• Creac’h C, Radat F, Mick G, et al. One or several types of triptan overuse headaches? Headache. 2009;49:519–528.
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Tepper DE. Breaking the cycle of medication overuse headache. Cleve Clin J Med. 2010;77:236–242.
   PubMed Web of Science ®Google Scholar
• Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005;26:62–68.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology. 1996;47:871–875.
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV. Refractoriness in migraine treatment: what are we talking about? Expert Rev Neurother. 2005;5:557–559.
   PubMedGoogle Scholar
• Riederer F, Marti M, Luechinger R, et al. Gray matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety. World J Biol Psychiatry. 2012;13:517–525.
   PubMed Web of Science ®Google Scholar
• Coppola G, Petolicchio B, Di Renzo A, et al. Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features. J Headache Pain. 2017;18:115–119.
   PubMedGoogle Scholar
• Lai TH, Chou KH, Fuh JL, et al. Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia. 2016;36:1324–1333.
   PubMed Web of Science ®Google Scholar
• Brooks J, Tracey I. From nociception to pain perception: imaging the spinal to supraspinal pathways. J Anat. 2005;207:19–33.
   PubMed Web of Science ®Google Scholar
• Mehnert J, Hebestreit J, May A. Cortical and subcortical alterations in medication overuse headache. Front Neurol. 2018;9:499.
   PubMed Web of Science ®Google Scholar
• Hof PR, Mufson EJ, Morrison JH. Human orbitofrontal cortex: cytoarchitecture and quantitative immune histochemical parcellation. J Comp Neurol. 1995;359:48–68.
   PubMed Web of Science ®Google Scholar
• Chanraud S, Di Scala G, Dilharreguy B, et al. Brain functional connectivity and morphology changes in medication-overuse headache: clue for dependency-related processes? Cephalalgia. 2014;34:605–615.
   PubMed Web of Science ®Google Scholar
• Fumal A, Laureys SD, Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006;129:543–550.
   PubMed Web of Science ®Google Scholar
• Grazzi L, Chiapparini L, Ferraro S, et al. Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache. 2010;50:998–1004.
   PubMed Web of Science ®Google Scholar
• Ferraro S, Grazzi L, Mandelli ML, et al. Pain processing in medication overuse headache: A functional magnetic resonance imaging (fMRI) study. Pain Med. 2012;13:255–262.
   PubMed Web of Science ®Google Scholar
• Munksgaard S, Madsen SK, Wienecke T. Treatment of medication overuse headache – A review. Acta Neurol Scand. 2019;139:405–414.
   PubMed Web of Science ®Google Scholar
• Olesen J. Detoxification for medication overuse is the primary task. Cephalalgia. 2012;32:420–422.
   PubMed Web of Science ®Google Scholar
• Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;18:891–902.
   PubMed Web of Science ®Google Scholar
• Pijpers JA, Louter MA, de Bruin ME, et al. Detoxification in medication-overuse headache, a retrospective controlled follow up study: does care by a headache nurse lead to cure? Cephalalgia. 2016;36:122–130.
   PubMed Web of Science ®Google Scholar
• Jevoux C Psychiatric comorbidities and personality disturbances in chronic headache patients. A follow up study [in portuguese] [Ph.D Thesis]. Universidade Federal Fluminense. Niterói; 2010.
   Google Scholar
• Tassorelli C, Jensen R, Allena M, et al. The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicenter study. Cephalalgia. 2017;37:1115–1125.
   PubMed Web of Science ®Google Scholar
• Kristoffersen ES, Straand J, Benth JS, et al. Predictors of successful primary care detoxification treatment for medication-overuse headache. Acta Neurol Scand. 2017;136:486–494.
   PubMed Web of Science ®Google Scholar
• Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicenter open-label trial. Cephalalgia. 2009;29:221–232.
   PubMed Web of Science ®Google Scholar
• Kristoffersen ES, Straand J, Russel MB, et al. Lasting improvement of medication-overuse headache after brief intervention – a long-term follow in primary care. Eur J Neurol. 2017;24:883–891.
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV. A short review on medication-overuse headache. Int J Neurorehabil. 2017;4:4.
   Google Scholar
• Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone versus structured detoxification programmes for medication-overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medication needs. Cephalalgia. 2006;26:1097–1105.
   PubMed Web of Science ®Google Scholar
• Hagen K, Stovner LJ. A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years. Acta Neurol Scand Suppl. 2011;124:38–43.
   Google Scholar
• Sarchielli P, Messina P, Cupini LM, et al. Sodium divalproate in migraine without aura and medication overuse headache: a randomized controlled trial. Eur Neuropsychopharmacol. 2014;24:1289–1297.
   PubMed Web of Science ®Google Scholar
• Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009;29:1021–1027.
   PubMed Web of Science ®Google Scholar
• Mei D, Ferraro D, Zelano G, et al. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol. 2006;29:269–275.
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Krymchantowski AGF, Jevoux CC. Medication-overuse headache. retrospective comparison of preventive treatments. Arq Neuropsiquiatr. 2018;76:668–673.
   PubMed Web of Science ®Google Scholar
• Rizzato B, Leone G, Misaggi G, et al. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse. Clin Neuropharmacol. 2011;34:74–78.
   PubMed Web of Science ®Google Scholar
• Pini LA, Guerzoni S, Cainazzo MM, et al. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. J Headache Pain. 2012;13:677–684.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017;27:1185–1215.
   PubMed Web of Science ®Google Scholar
• Ware MA, St Arnaud-Trempe E. The abuse potential of the synthetic cannabinoid nabilone. Addiction. 2010;105:494–503.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Blumenfeld AM, Cady RK, et al. Onabotulinumtoxin A for treatment of chronic migraine: PREEMPT 24-week pooled sub-group analysis of patients who had acute migraine medication overuse at baseline. J Neurol Sci. 2013;331:48–56.
   PubMed Web of Science ®Google Scholar
• Sandrini G, Perrotta A, Tassorelli C, et al. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: A multicenter, double-blind, randomized, placebo-controlled, parallel-group study. J Headache Pain. 2011;12:427–433.
   PubMed Web of Science ®Google Scholar
• Pijpers JA, Kies DA, Louter MA, et al. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: A double-blind randomized controlled trial. Brain. 2019;142:1203–1214.
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Diener HC, Ashina M, et al. Erenumab in chronic migraine with medication. Overuse Subgroup analysis of a randomized trial. Neurology. 2019;92:2309–2320.
   PubMed Web of Science ®Google Scholar
• Aurora SK, Ruff D, Pearlman EM. Medication overuse in a post-hoc analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine (Abstract). Proceedings of 61st annual scientific meeting american headache society, 2019 Jul 11-14; Indianapolis, USA. Headache. 2019;59:23.
   Google Scholar
• Bigal ME, Walter S, Rapoport AM. Fremanezumab as a preventive treatment for episodic and chronic migraine. Expert Rev Neurother. 2019;19:719–728.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017;377:2113–2122.
   PubMed Web of Science ®Google Scholar